<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38753991</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0987</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>The Pediatric infectious disease journal</Title><ISOAbbreviation>Pediatr Infect Dis J</ISOAbbreviation></Journal><ArticleTitle>A Pediatric Case of Encephalopathy With Hypoglycemia Induced by Coxsackievirus A4 Infection.</ArticleTitle><Pagination><StartPage>e324</StartPage><EndPage>e326</EndPage><MedlinePgn>e324-e326</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/INF.0000000000004390</ELocationID><Abstract><AbstractText>We report a pediatric case developing hypoglycemic encephalopathy during the acute phase of coxsackievirus (CV)-A4 infection. A part of the sequence of the virus detected from our patient was completely identical to that in other CV-A4 strain reported as a recombinant strain with lethal CV-A2, suggesting that the properties of CV-A4 might be associated with the severe hypoglycemic encephalopathy.</AbstractText><CopyrightInformation>Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoshina</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8005-0072</Identifier><AffiliationInfo><Affiliation>From the Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujimoto</LastName><ForeName>Tsuguto</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Surveillance, Immunization, and Epidemiologic Research.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Emergency Preparedness and Response.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Fungal Infection, National Institute of Infectious Diseases, Tokyo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanaoka</LastName><ForeName>Nozomu</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Surveillance, Immunization, and Epidemiologic Research.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Emergency Preparedness and Response.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konagaya</LastName><ForeName>Masami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Surveillance, Immunization, and Epidemiologic Research.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Division, UMA Corporation, Chiba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimbashi</LastName><ForeName>Reiko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Surveillance, Immunization, and Epidemiologic Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takanashi</LastName><ForeName>Sayaka</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Surveillance, Immunization, and Epidemiologic Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Surveillance, Immunization, and Epidemiologic Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka-Taya</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Surveillance, Immunization, and Epidemiologic Research.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusuhara</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Infect Dis J</MedlineTA><NlmUniqueID>8701858</NlmUniqueID><ISSNLinking>0891-3668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="Y">Brain Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>20</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38753991</ArticleId><ArticleId IdType="doi">10.1097/INF.0000000000004390</ArticleId><ArticleId IdType="pii">00006454-990000000-00865</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lin TY, Twu SJ, Ho MS, et al. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis. 2003;9:291–293.</Citation></Reference><Reference><Citation>Voss M, Pinkert S, Kespohl M, et al. A conserved cysteine residue in coxsackievirus B3 protein 3A with implication for elevated virulence. Viruses. 2022;14:769.</Citation></Reference><Reference><Citation>Guo WP, Chen GQ, Xie GC, et al. Mosaic genome of human coxsackievirus A4 associated with herpangina and HFMD in Yancheng, China, 2016 and 2018. Int J Infect Dis. 2020;96:538–540.</Citation></Reference><Reference><Citation>Yip CC, Lau SK, Woo PC, et al. Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012. Emerg Infect Dis. 2013;19:1285–1288.</Citation></Reference><Reference><Citation>Yang CR, Mason M, Parizel PM, et al. Magnetic resonance imaging patterns of paediatric brain infections: a pictorial review based on the Western Australian experience. Insights Imaging. 2022;13:160.</Citation></Reference><Reference><Citation>Sarma A, Hanzlik E, Krishnasarma R, et al. Human parechovirus meningoencephalitis: neuroimaging in the era of polymerase chain reaction-based testing. Am J Neuroradiol. 2019;40:1418–1421.</Citation></Reference><Reference><Citation>Kang EG, Jeon SJ, Choi SS, et al. Diffusion MR imaging of hypoglycemic encephalopathy. Am J Neuroradiol. 2010;31:559–564.</Citation></Reference><Reference><Citation>Moritani T, Smoker WR, Sato Y, et al. Diffusion-weighted imaging of acute excitotoxic brain injury. Am J Neuroradiol. 2005;26:216–228.</Citation></Reference><Reference><Citation>Kuno S, Itagaki A, Yamazaki I, et al. Pathogenicity of newly isolated coxsackievirus B4 for mouse pancreas. Acta Virol. 1984;28:433–436.</Citation></Reference><Reference><Citation>Flodström M, Horwitz MS, Maday A, et al. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology. 2001;281:205–215.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>